Find Academic Supervisors

• Hematology
• Medical Oncology
• Prostate Cancer
• +4 more

Kyle William Robinson serves as Clinical Associate Professor of Medicine in the Department of Medicine at the University of Pennsylvania's Perelman School of Medicine. He maintains clinical practice at the Abramson Cancer Center with hospital privileges at the Hospital of the University of Pennsylvania. His dual expertise spans Hematology and Medical Oncology, focusing on complex malignancies including prostate cancer, lung cancer, and lymphoma. His educational pathway includes: Medical Degree: Temple University School of Medicine Residency: Temple University Hospital Fellowship: Oregon Health & Science University Dr. Robinson's research program targets critical gaps in cancer therapeutics through three interconnected domains. His prostate cancer work investigates germline variants and racial disparities using real-world cohorts, while lung cancer research examines immunotherapy optimization including late toxicities and biomarker-driven combinations. In hematology, he analyzes response kinetics for novel lymphoma therapies. This portfolio demonstrates translational rigor with direct clinical applicability. Analysis of his 2021-2025 publications reveals consistent focus on evidence generation for precision oncology. Key themes include genetic epidemiology of prostate cancer, immunotherapy safety management in NSCLC, and biomarker-driven treatment sequencing. His work increasingly addresses health disparities and real-world implementation barriers alongside therapeutic innovation. At the Abramson Cancer Center, Dr. Robinson leads a multidisciplinary team integrating medical oncology, genomics, and supportive care. His clinical practice directly informs research questions while trial participation provides patients access to cutting-edge therapies. This bidirectional translation characterizes his academic medicine approach.

Rakesh VenkatView profile

Assistant Professor

• Theoretical Computer Science
• Approximation Algorithms
• Hardness of Approximation
• +1 more

Rakesh Venkat is an Assistant Professor in the Department of Computer Science and Engineering at the Indian Institute of Technology Hyderabad. His research focuses on Theoretical Computer Science, including approximation algorithms, hardness of approximation, and communication complexity. Education : Ph.D., Tata Institute of Fundamental Research (TIFR), Mumbai. Research Trends : His work addresses fundamental challenges in algorithm design, such as optimizing cache misses, improving clustering algorithms, analyzing graph expansion, and exploring embedding techniques. Publications span top-tier conferences like APPROX, FSTTCS, ICALP, and ITCS, with collaborations at institutions including HUJI, TIFR, and IIT-Bombay. Teaching : Courses taught include Approximation Algorithms, Advanced Data Structures, Discrete Mathematics, and Spectral Graph Theory.

• Biostatistics
• Clinical Statistics
• Health Science Research
• +9 more

Zhangsheng Yu is an Adjunct Professor in the Biostatistics Department at Yale School of Public Health , Yale University. He specializes in clinical statistics methods and health science collaborations. Research Interests : Advanced survival analysis for disease risk Panel count and cure rate models Deep learning in medical imaging High-dimensional mediation analysis Spatial transcriptomics algorithms AI in psychiatric clinical trials Publications : Recent work spans multimodal cancer prognosis, neurodegenerative disease modeling, and spatial gene expression analysis, with methodologies applied to liver/kidney diseases and psychiatric conditions. Professional Service : Serves as Associate Editor for Statistics in Medicine , Heart Rhythm , and Journal of Digestive Disease . Former President of Central Indiana Chapter of American Statistical Association and current Vice-President of Clinical Statistics Chapter of World Congress of Chinese Medicine.

Fereydoun DaneshgaranView profile

Professor

• Wireless Communications
• Digital Communications
• Coding Theory
• +7 more

Fereydoun Daneshgaran is a Professor and Chairman of the Electrical & Computer Engineering Department at California State University, Los Angeles, where he has served since 2006. He also directs the fiber and nonlinear optics research laboratory and has held various academic leadership positions including chairman of the Communications group and acting chairman of the ECE Department. Dr. Daneshgaran's educational background includes: Ph.D. in Communications, VLSI, and Optimization from UCLA (1992) M.S. (Magna Cum Laude) in Communications, Solid State Electronics, and Control Systems from Cal State LA (1985) B.S. (Magna Cum Laude) in Electrical and Mechanical Engineering from Cal State LA (1983) Dr. Daneshgaran's primary research interests focus on wireless communications, digital communications, and information theory. His work spans multiple specialized areas including coding theory (particularly Turbo Codes and LDPC codes), quantum key distribution, cognitive radio, and network localization. His research has significant applications in wireless networking protocols, particularly IEEE 802.11 standards, with numerous publications analyzing throughput performance under various network conditions. He has also made substantial contributions to optical communications and signal processing techniques. Dr. Daneshgaran's publication record shows a progression from foundational work in Viterbi decoding and turbo codes to more recent applications in quantum communications and advanced wireless network protocols. His research consistently bridges theoretical communications theory with practical implementations, as evidenced by both his extensive journal publications and industry experience. His scientific achievements include: Best Paper Award at First International Conference on Advances in Satellite and Space Communications (SPACOMM 2009) U.S. Patent No. US 2007/0079223 A1 for "A method and system for Information processing" Dr. Daneshgaran has supervised numerous Ph.D. students and visiting scholars, primarily from Politecnico University of Turin (POLITO), Italy, fostering international research collaborations. His academic leadership extends to developing and teaching the entire graduate sequence in digital communications at Cal State LA, along with specialized courses in wireless communications, cognitive radio, and optical communication systems. He has also maintained industry connections through various consulting roles and entrepreneurial ventures in communications technology. As director of the fiber and nonlinear optics research laboratory from 1994 to 2015, Dr. Daneshgaran led research in optical communications and related technologies. His work has bridged theoretical communications research with practical implementations, as evidenced by both his academic publications and industry experience founding companies like EuroConcepts S.r.l. and Quantum Bit Communications, LLC.

• Biomarkers in neurodegenerative diseases
• Alzheimer's disease
• Lewy body dementia
• +5 more

Kristian Steen Frederiksen serves as a Clinical Associate Professor at the University of Copenhagen's Department of Clinical Medicine and as a Senior Hospital Physician at Rigshospitalet's Department of Neurology. He is the director of the clinical trial unit at the Danish Dementia Research Centre (DDRC), where he leads drug intervention studies (phase I-IV) and clinical research in Alzheimer's disease, Huntington's disease, and related disorders. His work bridges academic research and clinical practice through a dual appointment with the Capital Region of Denmark and the University of Copenhagen. Dr. Frederiksen's research focuses on neurodegenerative dementia with particular emphasis on Alzheimer's disease and Lewy body dementia. His specific scientific focus includes biomarkers for early diagnostics and as outcome measures in intervention studies, investigation of pathophysiological mechanisms in neurodegenerative diseases, and the development of digital and imaging markers for clinical implementation. His work spans biomarker research, early disease manifestations, clinical applications, and digital innovation in dementia diagnostics. Analysis of his recent publications reveals a strong emphasis on diagnostic innovation, particularly in biomarker development for neurodegenerative diseases. His research integrates traditional biomarker approaches with digital health technologies and machine learning applications. A significant portion of his work addresses the implementation challenges of new therapies, particularly anti-amyloid treatments for Alzheimer's disease, reflecting his active role in European clinical guidelines development. Scientific Awards: Firkløver-fondens Hæderspris for Forskning 2025 (Firkløver Foundation Research Honor Prize) Dr. Frederiksen serves as Editor-in-Chief for Alzheimer's Research & Therapy (since June 2024) and has received substantial research funding from organizations including Alzheimer Forskningsfonden, Parkinsonforeningen, Innovation Fund Denmark, and industry partners. He acts as Principal or Sub-investigator and National Coordinator on multiple industry-sponsored phase 2 and 3 trials for Alzheimer's disease involving companies like Roche, Biogen, Novo Nordisk, and Eisai/Bioarctic. His extensive conflict of interest disclosures reflect his significant involvement in the dementia research ecosystem through editorial roles, advisory boards, and speaking engagements with major pharmaceutical companies. At the Danish Dementia Research Centre, Dr. Frederiksen leads a multidisciplinary team conducting cutting-edge research on dementia diagnostics and therapeutics. His clinical trial unit coordinates international studies while maintaining strong connections with European research networks including the European Alzheimer's Disease Consortium (EADC). His work bridges basic science, clinical application, and healthcare implementation, positioning him at the forefront of dementia research in Europe.